A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting Conditions

• Status: Withdrawn
• Trial end date: 2020-06-01

Summary

The purpose of the study is to investigate any difference in the extent and rate of absorption of doxylamine between the test (investigational medicinal product [IMP]) and reference products that could impact the bioavailability of the medication when administered under fasting conditions.

• Phase: Phase 1

Details

• Lead Sponsor: Grünenthal GmbH
• Collaborator: Grünenthal, S.A.
• Treatments: Dicyclomine, doxylamine, pyridoxine drug combination; Doxylamine; Doxylamine succinate; Pyridoxal; Pyridoxine; Vitamin B 6